Who to call at Teva Pharmaceutical Industries Ltd, and when
Fundz watches for the moments Teva Pharmaceutical Industries Ltd starts buying, and tells you who to reach.
- An alert the day Teva Pharmaceutical Industries Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Teva Pharmaceutical Industries Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Teva Pharmaceutical Industries Ltd. With Fundz connected, it knows.
Teva and Samsung Bioepis Sign Agreement for U.S. Rights to Biosimilars Infliximab and Etanercept.
Contract Type
agreement
Tel AvivManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Teva Pharmaceutical Industries has entered into a license and commercialization agreement with Samsung Bioepis to gain U.S. rights for biosimilars infliximab-abda and etanercept-ykro. This agreement will enhance Teva’s portfolio in the immunology sector, with manufacturing overseen by Samsung Bioepis and sales managed by Teva.
Quick answer
Teva and Samsung Bioepis Sign Agreement for U.S. Rights to Biosimilars Infliximab and Etanercept. (November 3, 2026). Teva Pharmaceutical Industries Ltd is based in Tel Aviv, Tel Aviv District, Israel.
- What agreement did Teva Pharmaceutical Industries Ltd announce on November 3, 2026?
- Teva Pharmaceutical Industries has entered into a license and commercialization agreement with Samsung Bioepis to gain U.S. rights for biosimilars infliximab-abda and etanercept-ykro. This agreement will enhance Teva’s portfolio in the immunology sector, with manufacturing overseen by Samsung Bioepis and sales managed by Teva.
- What does Teva Pharmaceutical Industries Ltd do?
- Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of people worldwide.
- Where is Teva Pharmaceutical Industries Ltd based?
- Teva Pharmaceutical Industries Ltd is based in Tel Aviv, Tel Aviv District, Israel.
- Which similar companies announced agreements around the same time?
- AbbVie Inc. (November 3, 2026), Sino Biopharmaceutical (November 13, 2026), Alexion (October 29, 2026) and Cognito Therapeutics (October 27, 2026) also announced agreements within 45 days of Teva Pharmaceutical Industries Ltd.
Source: Fundz verified event record.
Other recent agreements in Therapeutics and Pharmaceutical
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026)
- Sino Biopharmaceutical Partners with Boehringer Ingelheim in a $358 Million Oncology Deal (November 13, 2026)
- Wolves Foundation and Alexion extend partnership to support Wolves Disability FC and Wolves Wishes for three more years. (October 29, 2026)
- Rhode Island Life Science Hub and Cognito Therapeutics launch partnership for Alzheimer's research. (October 27, 2026)
- Celltrion Secures Exclusive Supply Agreement for Omlyclo and Aptozma with U.S. Healthcare Company to Expand Market Access. (October 26, 2026)
- Pfizer Partners with Blackstone Life Sciences to Co-Fund $1.5 Billion Development for Berobenatide Obesity Drug. (November 14, 2026)
Related People
Teva Pharmaceutical Industries Ltd signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.